FDA Approval of Interchangeable Biosimilar Means Patients Will Have Greater Access to Affordable Medications Provided by Local Pharmacists, Pharmacies
In an historic move last week, the Food and Drug Administration (FDA) approved Semglee (insulin glargine-yfgn) as the first interchangeable biosimilar product.